Ciftci, H S <br/><br/>
Influence of Proton Pump Inhibitors on Mycophenolic Acid Pharmacokinetics in Patients With Renal Transplantation and the Relationship With Cytochrome 2C19 Gene Polymorphism.  [electronic resource] 

 -  Transplantation proceedings  Apr 2017 
 - 490-496 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-2623 
<br/><br/><label>Standard No.: </label>10.1016/j.transproceed.2017.01.029  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Cytochrome P-450 CYP2C19--genetics<br/>Drug Interactions<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>Humans<br/>Immunosuppressive Agents--pharmacokinetics<br/>Kidney Transplantation<br/>Lansoprazole--therapeutic use<br/>Male<br/>Middle Aged<br/>Mycophenolic Acid--analogs & derivatives<br/>Polymorphism, Restriction Fragment Length<br/>Polymorphism, Single Nucleotide<br/>Proton Pump Inhibitors--therapeutic use<br/>Rabeprazole--therapeutic use<br/>Retrospective Studies<br/>Tacrolimus--therapeutic use